$14.34▾ 4.72%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$515.80MTTM operating cash
Pre-profit
It generates operating cash even though it has no reported profit yet.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+108.8%year over year
Strong
Revenue is growing strongly year over year.
Leverage
Highdebt to assets
Weak
High leverage relative to its assets.
More coming: dilution / share-count creep.
✦ The read
Core Scientific, Inc. - Tranche 1 Warrants is pre-profit. It generates operating cash even though it has no reported profit yet. Revenue is growing strongly year over year. High leverage relative to its assets.
Key numbers
Valuation
EPS (TTM)$-4.24
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin-325.9%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$440.31M
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.